Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

LAVA Therapeutics N.V. LVTX

Full chart Compare
Set alert

Price alert · LVTX

All alert types
1.74 0.00 (+0.00%)

At closeNov 28, 2025, 4:00 PM EST

1.74 Day range 1.74

52-week range unavailable

YTD
+82.97%
1 year
+8.75%

Financial health

Altman Z-Score

-4.74 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2019: -0.7×FY 2020: -0.4×FY 2021: -2.6×FY 2022: -2.8×FY 2023: -1.0×FY 2024: -1.0×
FY 2019 5y median -1.0× FY 2024
P/S 2.1×
FY 2019: 0.0×FY 2020: 96.8×FY 2021: 20.3×FY 2022: 4.7×FY 2023: 6.2×FY 2024: 2.1×
FY 2019 5y median 6.2× FY 2024
P/B 0.9×
FY 2019: 45.1×FY 2020: 47.6×FY 2021: 0.9×FY 2022: 1.1×FY 2023: 0.8×FY 2024: 0.9×
FY 2019 5y median 0.9× FY 2024
P/FCF -1.3×
FY 2019: -28.1×FY 2020: -37.0×FY 2021: -3.7×FY 2022: 26.3×FY 2023: -1.0×FY 2024: -1.3×
FY 2019 5y median -1.3× FY 2024
EV/EBITDA 0.2×
FY 2019: -27.6×FY 2020: -24.7×FY 2021: -0.6×FY 2022: 0.1×FY 2023: -0.1×FY 2024: 0.2×
FY 2019 5y median -0.1× FY 2024
EV/Sales -0.4×
FY 2019: 0.0×FY 2020: 93.6×FY 2021: 4.2×FY 2022: -0.2×FY 2023: 0.6×FY 2024: -0.4×
FY 2019 5y median 0.6× FY 2024
FCF Yield -76.7%
FY 2019: -3.6%FY 2020: -2.7%FY 2021: -27.1%FY 2022: 3.8%FY 2023: -97.1%FY 2024: -76.7%
FY 2019 5y median -27.1% FY 2024

Profitability

Gross Margin 100.0%
FY 2019: 0.0%FY 2020: -319.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 48.6%FY 2024: 100.0%
FY 2019 5y median 100.0% FY 2024
Operating Margin -247.8%
FY 2019: 0.0%FY 2020: -391.6%FY 2021: -815.2%FY 2022: -179.7%FY 2023: -641.1%FY 2024: -247.8%
FY 2019 5y median -391.6% FY 2024
Net Margin -209.6%
FY 2019: 0.0%FY 2020: -425.1%FY 2021: -791.7%FY 2022: -164.5%FY 2023: -618.6%FY 2024: -209.6%
FY 2019 5y median -425.1% FY 2024
ROE -90.5%
FY 2019: -165.8%FY 2020: -209.0%FY 2021: -35.8%FY 2022: -37.1%FY 2023: -81.8%FY 2024: -90.5%
FY 2019 5y median -81.8% FY 2024
ROIC -43.6%
FY 2019: -125.9%FY 2020: -109.8%FY 2021: -34.0%FY 2022: -27.5%FY 2023: -46.9%FY 2024: -43.6%
FY 2019 5y median -43.6% FY 2024
ROA -31.1%
FY 2019: -110.1%FY 2020: -77.7%FY 2021: -30.4%FY 2022: -22.2%FY 2023: -41.2%FY 2024: -31.1%
FY 2019 5y median -31.1% FY 2024

Growth (YoY)

Revenue 77.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 42.8%FY 2022: 262.4%FY 2023: -65.1%FY 2024: 77.0%
FY 2019 FY 2024
Operating Income 31.6%
FY 2019: 0.0%FY 2020: -53.1%FY 2021: -197.2%FY 2022: 20.1%FY 2023: -24.6%FY 2024: 31.6%
FY 2019 FY 2024
EPS (diluted) 40.1%
FY 2019: 0.0%FY 2020: -84.3%FY 2021: 94.6%FY 2022: 42.5%FY 2023: -27.6%FY 2024: 40.1%
FY 2019 FY 2024
Free Cash Flow 52.3%
FY 2019: 0.0%FY 2020: -4.6%FY 2021: -199.8%FY 2022: 111.8%FY 2023: -1286.7%FY 2024: 52.3%
FY 2019 FY 2024

Financial Health

Current Ratio 4.4×
FY 2019: 5.4×FY 2020: 2.5×FY 2021: 12.1×FY 2022: 6.4×FY 2023: 6.6×FY 2024: 4.4×
FY 2019 5y median 6.4× FY 2024
Quick Ratio 4.4×
FY 2019: 5.4×FY 2020: 2.5×FY 2021: 12.1×FY 2022: 6.4×FY 2023: 6.6×FY 2024: 4.4×
FY 2019 5y median 6.4× FY 2024
Debt / Equity 0.2×
FY 2019: 0.3×FY 2020: 0.5×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×
FY 2019 5y median 0.1× FY 2024
Net Debt / EBITDA 1.3×
FY 2019: 0.6×FY 2020: 0.8×FY 2021: 2.1×FY 2022: 3.1×FY 2023: 0.9×FY 2024: 1.3×
FY 2019 5y median 1.3× FY 2024
Interest Coverage -57.7×
FY 2019: -110×FY 2020: -42.9×FY 2021: -69.8×FY 2022: -425×FY 2023: -92.3×FY 2024: -57.7×
FY 2019 5y median -69.8× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31